This announcement is a separate document:
德琪醫藥-B：自願公告 澳門藥物監督管理局批准ATG-010（塞利尼索）用於治療復發性及/或難治性多發性骨髓瘤的新藥上市申請
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.